View Older Stories View More Recent Stories

Oct 1, 2021 08:09AM Precigen (PGEN) Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
Oct 1, 2021 08:05AM Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
Sep 1, 2021 08:05AM Precigen to Present at the 2021 Wells Fargo Virtual Healthcare Conference and the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 9, 2021 04:01PM Precigen Reports Second Quarter and First Half 2021 Financial Results
Aug 2, 2021 04:05PM Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9th
Jun 10, 2021 05:07PM Precigen Inc. (PGEN) Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
Jun 10, 2021 05:05PM Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
Jun 10, 2021 04:05PM Precigen to Present at the JMP Securities Life Sciences Conference
May 10, 2021 04:30PM Precigen Reports First Quarter 2021 Financial Results
Mar 30, 2021 04:11PM Precigen Inc. (PGEN) Announces Departure of Chief Financial Officer
Mar 30, 2021 04:05PM Precigen Announces Departure of Chief Financial Officer
Mar 23, 2021 08:05AM Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
Mar 18, 2021 08:31AM Precigen Inc. (PGEN) Receives FDA Orphan Drug Designation for PRGN-2012 AdenoVerse Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
Mar 18, 2021 08:30AM Precigen Receives FDA Orphan Drug Designation for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
Mar 1, 2021 04:05PM Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 22, 2021 04:05PM Precigen to Announce Fourth Quarter and Full Year 2020 Financial Results on March 1st
Feb 4, 2021 04:05PM Precigen to Participate in Guggenheim Healthcare Talks Oncology Day
Jan 13, 2021 04:05PM Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference
Jan 6, 2021 08:05AM Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 5, 2021 08:06AM Precigen Inc. (PGEN) Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
Jan 5, 2021 08:05AM Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
Dec 15, 2020 07:37PM Precigen Provides Latest Clinical Developments at Virtual R&D Update Event
Dec 8, 2020 04:05PM Precigen to Host R&D Update Virtual Event on December 15th to Share Latest Clinical Developments
Dec 7, 2020 10:05AM Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of PRGN-3006 UltraCAR-T® at the 62nd ASH Annual Meeting and Exposition
Oct 8, 2020 09:00AM Lt. General (Ret.) Thomas Bostick Appointed to CSX Corp. Board of Directors
Sep 8, 2020 07:30AM Precigen to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Aug 17, 2020 07:31AM Precigen Inc. (PGEN) Reports First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse Immunotherapy to Treat HPV-associated Cancers
Aug 17, 2020 07:30AM Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers
Aug 10, 2020 04:10PM Precigen Reports Second Quarter and First Half 2020 Financial Results
Aug 10, 2020 07:36AM Precigen, Inc. (PGEN) Reports Phase 1b Study of AG019 ActoBiotics Met Primary Endpoint Assessing Safety and Tolerability
Aug 10, 2020 07:30AM Precigen ActoBio Announces Positive Topline Results from Phase 1b Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
Aug 6, 2020 07:54AM Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001
Aug 6, 2020 07:30AM Precigen Triple-Gene Provides Six-month Follow-up Data from Phase I Study of INXN-4001, a Multigenic Investigational Therapeutic Candidate for Heart Failure
Aug 3, 2020 07:30AM Precigen to Announce Second Quarter and First Half 2020 Financial Results on August 10th
Jun 22, 2020 08:48AM Precigen, Inc. (PGEN) Announces Preclinical Data for PRGN-3005 UltraCAR-T Demonstrate Superior Expansion and Persistence of UltraCAR-T Compared to Traditional CAR-T
Jun 22, 2020 08:45AM Preclinical Data for PRGN-3005 UltraCAR-T® Demonstrate Superior Expansion and Persistence of UltraCAR-T Compared to Traditional CAR-T
Jun 11, 2020 07:30AM Precigen to Participate in Upcoming JMP Securities Hematology and Oncology Forum
Jun 4, 2020 04:05PM Notice: Precigen Announces Date and Location Change for its 2020 Annual Meeting of Shareholders
May 15, 2020 07:30AM Precigen to Present Preclinical Data for PRGN-3005 UltraCAR-T™ at the AACR Virtual Annual Meeting II in June 2020
May 6, 2020 04:05PM Precigen Reports First Quarter 2020 Financial Results
Apr 29, 2020 07:30AM Precigen to Announce First Quarter 2020 Financial Results on May 6th
Apr 20, 2020 07:39AM Precigen, Inc. (PGEN) Reports IND Approval to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse Immunotherapy
Apr 20, 2020 07:36AM Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
Mar 2, 2020 04:05PM Precigen Reports Fourth Quarter and Year End 2019 Financial Results
Feb 24, 2020 07:30AM Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd
Feb 3, 2020 07:30AM Precigen Completes Series Of Transactions To Solidify Healthcare Focus
View More Recent Stories View Older Stories